An observational study in Chest Trauma, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.
Sponsored by Assiut University · Observational
Thoracic trauma is a critical clinical entity and a major global public health burden, representing the second most frequently occurring unintentional traumatic injury and the third most common cause of death-following head and abdominal injuries-in patients with polytrauma. It places a substantial demand on emergency departments and directly accounts for 20% to 25% of all trauma-related fatalities worldwide(1). The severity of these injuries is underscored by persistently high mortality rates, which can reach up to 60% in cases of severe blunt chest trauma depending on the healthcare setting. Recent epidemiological data indicates that among potentially preventable trauma deaths, thoracic injuries represent up to 41%, with blunt mechanisms such as motor vehicle collisions acting as the primary driver (accounting for 80% to 92% of cases)(2). Given this significant risk profile, rapid and accurate clinical triage is vital. Current evidence consistently demonstrates that early recognition, protocolized multidisciplinary management, and the timely provision of definitive interventions at dedicated trauma centers are essential to decreasing morbidity and significantly reducing preventable trauma mortality(3).Effective initial assessment in the ED relies heavily on validated trauma scoring systems. GCS is the most universally utilized tool for evaluating a patient's level of consciousness, calculating a score between 3 and 15 based on three physiological parameters: eye opening, verbal response, and motor response. RTS is a broader physiological scoring system combining the GCS, systolic blood pressure, and respiratory rate. CTS is a specific, targeted assessment tool designed to quantify the severity of thoracic injuries.
72 studies on the registry are indexed under Thoracic Injuries; 18 are open to participants now.
This study's planned enrollment of 100 is below the median of 150 across 32 observational studies indexed under Thoracic Injuries.
Browse Thoracic Injuries studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with documented clinical or radiological evidence of chest injury (e.g., rib fractures, pulmonary contusion, pneumothorax, or hemothorax confirmed via X-ray, chest CT, or FAST).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with documented clinical or radiological evidence of chest injury (e.g., rib fractures, pulmonary contusion, pneumothorax, or hemothorax confirmed via X-ray, chest CT, or FAST
diagnositic acuracy of the Glasgow Coma Scale (GCS), in cases of thoracic trauma.
Time frame: baseline
diagnostic acuracy of the Revised Trauma Score (RTS) in cases of thoracic trauma.
Time frame: baseline
diagnostic acuracy of the Chest Trauma Score (CTS) in cases of thoracic trauma.
Time frame: baseline
No study locations are listed for this record.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.